Home
Merck Group
Archive
Newsletter
Deutsch
Sitemap
Search
RSS
Home
Life and Assistance
Life and Quality
Life and Responsibility
Life and Style
Life and Assistance
Flexibility helps
When you’re suddenly diagnosed with multiple sclerosis (MS), how does it affect your working life? The disease is not that uncommon: Statistically speaking, in a company with about 750 employees, one person will be affected by MS. Despite typical symptoms such as chronic fatigue, many people are still able to continue working. Openness and consideration can be a huge help.
Cooperating for faster results
In the pharmaceutical industry, cooperating with partners can reduce the time needed to develop drugs, which means faster, more efficient help for patients. Such collaboration requires ideas — not only for the development of technologies, but also for cooperation involving very different partners. Here are some examples of Merck Serono’s experiences.
Back to the Roots
Meat consumption is considered an indicator of prosperity — the more, the better. However, gourmet chef Michael Hoffmann has dedicated himself to making new discoveries in the realm of vegetarian cuisine. He's moving fennel, Jerusalem artichoke, and celeriac from the edges to the middle of the plate. His recipes are the result of many experiments in the kitchen as well as the garden.
Golden anniversary for a great cold treatment
It’s 50 years old and still going strong: Nasivin® cold medicine from Merck first debuted on the market in 1961. The nose drops containing the active ingredient oxymetazoline have since grown into an entire product family that’s helping people to breathe more easily in over 60 countries.
Growth factor for new cartilage cells
Like a good spring mattress, healthy articular cartilage is firm and elastic. It cushions blows, carries the body’s weight, and protects the bone surface of joints. Osteoarthritis leads to the softening and eventual loss of this cartilage. Now, however, a new biologic that induces cartilage cell growth may well become the first therapy to treat the causes of this degenerative disease.
Read more
Archive
Most Read Articles
CONTACT US
Contact to Merck
NEWSLETTER
Explorer Magazine Newsletter
SERVICES
Recommend Page
//SRC=“SDC-Server/SDCID